Pubmed Latest “Exploring SGLT2 Inhibitors for Diabetes Management Beyond Type 2” by satcit 8 January 2024 written by satcit 8 January 2024 68 https://pubmed.ncbi.nlm.nih.gov/38117995 The scientific abstract suggests that the use of SGLT2 inhibitors for diabetes management is being explored beyond type 2 diabetes. 0 comment 0 FacebookTwitterPinterestLinkedinTumblrRedditWhatsappTelegramEmail satcit previous post “Infant Adiposity Linked to Later Adverse Metabolic Health: A Study” next post “Potential of Type 2 Diabetes Remission as New Focus in Diabetes Care: A Scientific Abstract” You may also like “Addressing Modifiable Risk Factors to Improve Cardiovascular Outcomes:... 8 January 2024 “Modifiable Risk Factors’ Impact on Cardiovascular Outcomes: A... 8 January 2024 “Semaglutide May Improve Heart Failure in Obese Patients... 8 January 2024 Semaglutide’s Potential Beneficial Effects on Heart Failure with... 8 January 2024 “Semaglutide May Lower Heart Failure Hospitalization Risk in... 8 January 2024 “Semaglutide May Reduce Cardiovascular Risks in Heart Failure... 8 January 2024 “Methemoglobinemia Outbreak in Japanese Neonatal ICU and Maternity... 8 January 2024 “New Perspectives on Medical Ethics: A Commentary in... 8 January 2024 “Balancing Probability and Precision in Designing Future ARDS... 8 January 2024 “Evaluating Doxycycline Postexposure Prophylaxis for Preventing Sexually Transmitted... 8 January 2024 Leave a Comment Cancel Reply Save my name, email, and website in this browser for the next time I comment.